BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/01/2024- NAV $52.57
- NAV Change $+2.19
- Market Price $52.58
- Market Price Change $+2.13
- Trading Volume (M) 21,928
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/01/2024- NAV $52.57
- NAV Change $+2.19
- Market Price $52.58
- Market Price Change $+2.13
- Trading Volume (M) 21,928
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 5/01/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
42.05% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 35,920,922 | -- | 8,446 | -- |
37.65% | -- | NASDAQ BIO INDEX SWAP BNP | 32,161,262 | -- | 7,562 | -- |
19.38% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 16,556,968 | -- | 3,893 | -- |
14.62% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 12,486,837 | -- | 2,936 | -- |
6.58% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,618,226 | -- | 1,321 | -- |
6.10% | AMGN | AMGEN INC | -- | $5,210,395.45 | 18,785 | 2023607 |
5.76% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,916,563.64 | 12,226 | 2931034 |
5.63% | REGN | REGENERON PHARMACEUTICALS | -- | $4,811,934.48 | 5,326 | 2730190 |
5.47% | GILD | GILEAD SCIENCES INC | -- | $4,673,679.93 | 71,343 | 2369174 |
5.19% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,431,636 | -- | 1,042 | -- |
3.42% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,921,689.17 | 38,237 | 2989044 |
3.40% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 2,904,806 | -- | 683 | -- |
3.27% | MRNA | MODERNA INC | -- | $2,796,642.86 | 25,091 | BGSXTS3 |
2.41% | BIIB | BIOGEN INC | -- | $2,062,960.85 | 9,545 | 2455965 |
1.52% | ILMN | ILLUMINA INC | -- | $1,300,786.44 | 10,433 | 2613990 |
1.45% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,240,469.12 | 8,272 | B00FWN1 |
1.21% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,032,208.71 | 12,387 | 2437071 |
1.09% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $934,987.11 | 6,537 | 2623911 |
1.06% | VTRS | VIATRIS INC | -- | $906,907.40 | 77,980 | BMWS3X9 |
1.05% | SNY | SANOFI-ADR | -- | $899,939.64 | 17,988 | 2964557 |
0.96% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $823,405.38 | 29,334 | BMVP7Y0 |
0.94% | SRPT | SAREPTA THERAPEUTICS INC | -- | $806,867.60 | 6,164 | B8DPDT7 |
0.94% | MEDP | MEDPACE HOLDINGS INC | -- | $804,075.06 | 2,021 | BDCBC61 |
0.92% | UTHR | UNITED THERAPEUTICS CORP | -- | $788,892.88 | 3,092 | 2430412 |
0.92% | ARGX | ARGENX SE - ADR | -- | $783,163.62 | 2,043 | BDVLM39 |
0.91% | INCY | INCYTE CORP | -- | $780,653.24 | 14,746 | 2471950 |
0.69% | ROIV | ROIVANT SCIENCES LTD | -- | $593,188.36 | 52,916 | BMW4NZ9 |
0.67% | BNTX | BIONTECH SE-ADR | -- | $571,722.20 | 6,356 | BK6H543 |
0.62% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $532,030.73 | 3,773 | BV9G6B8 |
0.54% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $462,562.80 | 6,360 | BHCB0P4 |
0.53% | PCVX | VAXCYTE INC | -- | $453,360.36 | 7,116 | BKPVGH6 |
0.53% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $451,388.52 | 4,092 | B4Q5ZN4 |
0.51% | EXEL | EXELIXIS INC | -- | $436,548.68 | 19,911 | 2576941 |
0.50% | CYTK | CYTOKINETICS INC | -- | $428,444.57 | 6,761 | BBBSBJ5 |
0.50% | BGNE | BEIGENE LTD-ADR | -- | $425,605.07 | 2,719 | BYYWPW6 |
0.49% | RVMD | REVOLUTION MEDICINES INC | -- | $419,915.94 | 10,817 | BL71K91 |
0.48% | IONS | IONIS PHARMACEUTICALS INC | -- | $411,777.74 | 9,574 | BDJ0LS6 |
0.45% | BPMC | BLUEPRINT MEDICINES CORP | -- | $381,526.92 | 4,022 | BWY52P3 |
0.44% | IBRX | IMMUNITYBIO INC | -- | $374,419.22 | 43,843 | BNSP0B8 |
0.43% | APLS | APELLIS PHARMACEUTICALS INC | -- | $364,762.05 | 7,921 | BYTQ6X1 |
0.38% | HALO | HALOZYME THERAPEUTICS INC | -- | $327,211.80 | 8,326 | 2975098 |
0.37% | BBIO | BRIDGEBIO PHARMA INC | -- | $312,061.35 | 11,545 | BK1KWG8 |
0.35% | KRYS | KRYSTAL BIOTECH INC | -- | $296,347.52 | 1,856 | BD6JX35 |
0.33% | CRSP | CRISPR THERAPEUTICS AG | -- | $283,686.32 | 5,272 | BDHF4K6 |
0.33% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $278,167.60 | 4,306 | BYX38M1 |
0.32% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $275,451.72 | 1,308 | BD59BS7 |
0.32% | NUVL | NUVALENT INC-A | -- | $272,143.80 | 3,852 | BMVBZD3 |
0.32% | IMVT | IMMUNOVANT INC | -- | $272,080.80 | 9,540 | BJRFSB7 |
0.31% | ALKS | ALKERMES PLC | -- | $263,389.70 | 10,970 | B3P6D26 |
0.29% | INSM | INSMED INC | -- | $249,451.32 | 9,748 | 2614487 |
0.27% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $234,166.40 | 5,408 | BJ62Z18 |
0.27% | AXSM | AXSOME THERAPEUTICS INC | -- | $232,833.01 | 3,109 | BYZR4X4 |
0.27% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $230,191.32 | 5,234 | BMX9K07 |
0.27% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $229,262.50 | 18,341 | BF0DMK7 |
0.27% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $226,846.12 | 4,843 | BGMGM89 |
0.25% | SMMT | SUMMIT THERAPEUTICS INC | -- | $216,557.20 | 46,076 | BMTVQS7 |
0.25% | FTRE | FORTREA HOLDINGS INC | -- | $216,489.06 | 5,829 | BRXYZ57 |
0.25% | XENE | XENON PHARMACEUTICALS INC | -- | $210,452.97 | 4,953 | BRJ3GY4 |
0.24% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $206,013.65 | 4,573 | BDD19F8 |
0.24% | FOLD | AMICUS THERAPEUTICS INC | -- | $202,289.85 | 19,395 | B19FQ48 |
0.24% | IDYA | IDEAYA BIOSCIENCES INC | -- | $201,534.92 | 4,894 | BK0VHF6 |
0.23% | JANX | JANUX THERAPEUTICS INC | -- | $193,539.94 | 3,326 | BMFX8Y7 |
0.22% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $188,557.46 | 8,138 | BYQBFJ8 |
0.22% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $184,532.15 | 10,823 | 2713317 |
0.21% | ACLX | ARCELLX INC | -- | $180,803.70 | 3,465 | BPCJ1Q2 |
0.21% | MRUS | MERUS NV | -- | $178,770.04 | 3,802 | BZBY005 |
0.20% | PTCT | PTC THERAPEUTICS INC | -- | $171,790.64 | 5,029 | B17VCN9 |
0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $163,482.78 | 3,946 | BF2YWG4 |
0.17% | VCEL | VERICEL CORP | -- | $149,290.68 | 3,171 | BSBMN89 |
0.17% | DNLI | DENALI THERAPEUTICS INC | -- | $147,653.92 | 9,137 | BD2B4V0 |
0.17% | GERN | GERON CORP | -- | $146,288.40 | 35,855 | 2370381 |
0.17% | VERA | VERA THERAPEUTICS INC | -- | $145,961.68 | 3,449 | BL55460 |
0.17% | GH | GUARDANT HEALTH INC | -- | $145,952.18 | 7,993 | BFXC911 |
0.17% | KYMR | KYMERA THERAPEUTICS INC | -- | $145,431.12 | 4,013 | BMPRZV5 |
0.17% | ARVN | ARVINAS INC | -- | $145,250.56 | 4,472 | BDZ30Q0 |
0.17% | NTLA | INTELLIA THERAPEUTICS INC | -- | $142,042.50 | 6,313 | BYZM6C2 |
0.16% | SANA | SANA BIOTECHNOLOGY INC | -- | $139,423.14 | 14,478 | BMFJJ97 |
0.16% | DYN | DYNE THERAPEUTICS INC | -- | $137,622.24 | 5,328 | BN15WD1 |
0.16% | KROS | KEROS THERAPEUTICS INC | -- | $136,392.36 | 2,363 | BM7V485 |
0.16% | RNA | AVIDITY BIOSCIENCES INC | -- | $135,114.60 | 5,237 | BMWHPY1 |
0.16% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $134,534.80 | 5,305 | BZ1LFB2 |
0.16% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $133,918.32 | 5,944 | BDFKQ07 |
0.16% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $133,630.15 | 2,263 | BLCD809 |
0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $132,846.56 | 3,157 | BNFWZS4 |
0.15% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $125,666.72 | 3,196 | BQS9486 |
0.15% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $124,407.78 | 14,917 | BM9FJ13 |
0.15% | APGE | APOGEE THERAPEUTICS INC | -- | $124,220.40 | 2,440 | BM9HHL5 |
0.15% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $124,138.08 | 3,688 | BCBVTX1 |
0.14% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $122,592.60 | 5,580 | BN7Q7R7 |
0.14% | TWST | TWIST BIOSCIENCE CORP | -- | $121,352.12 | 3,797 | BGKG6G7 |
0.14% | BEAM | BEAM THERAPEUTICS INC | -- | $116,591.62 | 5,363 | BK6L288 |
0.14% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $116,227.14 | 6,114 | BKY5JZ8 |
0.13% | MYGN | MYRIAD GENETICS INC | -- | $114,931.41 | 5,903 | 2614153 |
0.13% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $112,755.75 | 3,725 | BKSGZN7 |
0.13% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $108,017.28 | 3,591 | B72ZBG4 |
0.13% | -- | AVADEL PHARMACEUTICALS | -- | $107,900.83 | 5,893 | BDGMC59 |
0.12% | INBX | INHIBRX INC | -- | $106,707.30 | 3,111 | BK1MBC3 |
0.12% | FUSN | FUSION PHARMACEUTICALS INC | -- | $101,787.84 | 4,752 | BJK0NH0 |
0.12% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $101,469.84 | 5,736 | BLB0YH0 |
0.12% | KURA | KURA ONCOLOGY INC | -- | $101,400.00 | 5,000 | BYZD465 |
0.12% | ARDX | ARDELYX INC | -- | $101,014.02 | 15,282 | BN89V40 |
0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $100,191.04 | 8,578 | BRJZSK0 |
0.12% | ADMA | ADMA BIOLOGICS INC | -- | $99,949.95 | 14,985 | B9NSBM2 |
0.12% | VCYT | VERACYTE INC | -- | $99,281.16 | 4,932 | BFTWZY0 |
0.11% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $97,767.00 | 3,825 | BDCBCD8 |
0.11% | XNCR | XENCOR INC | -- | $96,031.09 | 4,013 | BGCYWN8 |
0.11% | ANIP | ANI PHARMACEUTICALS INC | -- | $91,997.16 | 1,383 | BCDWBX6 |
0.11% | MORF | MORPHIC HOLDING INC | -- | $91,853.48 | 3,284 | BK8M4J4 |
0.10% | NVCR | NOVOCURE LTD | -- | $89,562.20 | 7,030 | BYSS4X4 |
0.10% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $84,509.82 | 10,281 | B3MZ6K5 |
0.10% | LGND | LIGAND PHARMACEUTICALS | -- | $83,061.46 | 1,163 | 2501578 |
0.10% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $83,025.30 | 3,270 | BKLXFX5 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $82,359.20 | 3,056 | B3X26D8 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $79,300.22 | 2,099 | BX7RSN3 |
0.09% | GMAB | GENMAB A/S -SP ADR | -- | $79,120.00 | 2,752 | BBC9WC7 |
0.09% | CGEM | CULLINAN THERAPEUTICS INC | -- | $78,932.90 | 2,809 | BM90J52 |
0.09% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $78,677.48 | 3,059 | BJDX8Y8 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $77,480.10 | 8,865 | BK4PZ38 |
0.09% | MNKD | MANNKIND CORP | -- | $77,065.38 | 17,757 | BF081J4 |
0.09% | PRTA | PROTHENA CORP PLC | -- | $75,569.76 | 3,528 | B91XRN2 |
0.09% | AKRO | AKERO THERAPEUTICS INC | -- | $74,215.68 | 3,696 | BK7Y2V9 |
0.09% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $73,136.12 | 8,686 | BMCWKZ2 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $73,070.01 | 2,249 | BMH5RL1 |
0.09% | ABCL | ABCELLERA BIOLOGICS INC | -- | $72,670.50 | 19,225 | BL53SR3 |
0.08% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $70,880.48 | 4,738 | BFZQ0L8 |
0.08% | VRNA | VERONA PHARMA PLC - ADR | -- | $67,911.64 | 4,462 | BYWPZK5 |
0.07% | MGNX | MACROGENICS INC | -- | $63,366.25 | 4,075 | BFDV8K0 |
0.07% | INVA | INNOVIVA INC | -- | $63,234.96 | 4,152 | BDDXF67 |
0.07% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $61,873.23 | 13,539 | 2100362 |
0.07% | SPRY | ARS PHARMACEUTICALS INC | -- | $58,825.65 | 6,305 | BMCR7V2 |
0.07% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $57,836.24 | 3,206 | BMGS7L1 |
0.07% | RLAY | RELAY THERAPEUTICS INC | -- | $57,369.24 | 8,614 | BN2R582 |
0.07% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $56,652.20 | 2,341 | BKDQKM6 |
0.07% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $56,222.40 | 6,360 | BKX9VD3 |
0.06% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $55,444.62 | 3,273 | BLN7XQ1 |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $54,374.32 | 8,008 | B8K7T65 |
0.06% | ETNB | 89BIO INC | -- | $53,558.75 | 6,121 | BK1K484 |
0.06% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $52,727.22 | 4,662 | BMQ5T49 |
0.06% | SAGE | SAGE THERAPEUTICS INC | -- | $52,456.00 | 3,950 | BP4GNK9 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $51,706.80 | 3,252 | BD9GVY0 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $50,905.60 | 2,624 | BD0MGM0 |
0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $50,057.64 | 3,954 | BMDWW66 |
0.06% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $49,374.00 | 9,495 | BFWLC09 |
0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $49,037.87 | 1,757 | BKC9SX3 |
0.06% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $48,942.40 | 2,704 | BMFD115 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $48,761.44 | 6,698 | BP2P6L0 |
0.06% | YMAB | Y-MABS THERAPEUTICS INC | -- | $47,441.73 | 2,877 | BG31GH0 |
0.06% | EOLS | EVOLUS INC | -- | $47,362.86 | 3,753 | BDRJH21 |
0.06% | RGNX | REGENXBIO INC | -- | $47,304.00 | 2,920 | BZ0G875 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $47,283.39 | 6,823 | BLR6XK8 |
0.05% | ANAB | ANAPTYSBIO INC | -- | $45,430.92 | 1,746 | BDRW1L7 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $45,428.04 | 8,012 | BYZG9R0 |
0.05% | IRON | DISC MEDICINE INC | -- | $45,134.46 | 1,582 | BMGJZJ8 |
0.05% | SVRA | SAVARA INC | -- | $43,995.60 | 8,888 | BYXGN81 |
0.05% | SIGA | SIGA TECHNOLOGIES INC | -- | $43,463.79 | 4,666 | 2107437 |
0.05% | NVAX | NOVAVAX INC | -- | $42,917.30 | 9,190 | BJDQXG4 |
0.05% | NRIX | NURIX THERAPEUTICS INC | -- | $41,986.80 | 3,210 | BMVLGP2 |
0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $41,275.92 | 4,424 | BKVDFF7 |
0.05% | PRME | PRIME MEDICINE INC | -- | $40,341.85 | 7,655 | BPBJFM7 |
0.05% | ZYME | ZYMEWORKS INC | -- | $40,269.72 | 4,597 | BPCQZY9 |
0.05% | CSTL | CASTLE BIOSCIENCES INC | -- | $39,746.10 | 1,805 | BKLCWZ3 |
0.05% | CVAC | CUREVAC NV | -- | $38,957.65 | 14,701 | BN4RD42 |
0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $38,876.05 | 16,685 | BN6MB18 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $38,176.60 | 2,035 | BYXV9H7 |
0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $38,024.64 | 1,296 | B292NQ7 |
0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $37,627.20 | 3,618 | BMZ4LN0 |
0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $36,972.00 | 9,243 | BFMLGR4 |
0.04% | OCUL | OCULAR THERAPEUTIX INC | -- | $36,339.78 | 7,239 | BNZB1X8 |
0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $35,094.96 | 3,702 | BLB0YQ9 |
0.04% | CABA | CABALETTA BIO INC | -- | $34,921.74 | 2,814 | BK5MWR1 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $34,826.86 | 3,761 | BJLKVS6 |
0.04% | OABI | OMNIAB INC | -- | $34,806.48 | 7,633 | BN13S71 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $34,585.60 | 2,702 | BP9N0G0 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $33,263.58 | 2,731 | BD06CS0 |
0.04% | ALEC | ALECTOR INC | -- | $33,195.36 | 6,287 | BJ4LDC4 |
0.04% | VERV | VERVE THERAPEUTICS INC | -- | $32,946.00 | 5,491 | BNKGXX2 |
0.04% | PETQ | PETIQ INC | -- | $32,339.79 | 1,917 | BDH65C8 |
0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $32,260.16 | 11,048 | BFZNYB7 |
0.04% | THRD | THIRD HARMONIC BIO INC | -- | $30,191.14 | 2,653 | BNNPQY8 |
0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $29,982.00 | 4,997 | BLFGJD5 |
0.04% | HUMA | HUMACYTE INC | -- | $29,937.60 | 6,804 | BMYTJP4 |
0.03% | FULC | FULCRUM THERAPEUTICS INC | -- | $29,818.44 | 4,068 | BJDX8Z9 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $29,803.40 | 3,565 | BY7RB53 |
0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $29,738.93 | 17,597 | B4N8MH9 |
0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $29,712.76 | 12,278 | BNC1BX1 |
0.03% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $29,619.59 | 11,011 | BZ0QMB7 |
0.03% | EDIT | EDITAS MEDICINE INC | -- | $29,401.25 | 5,375 | BZ8FPH3 |
0.03% | URGN | UROGEN PHARMA LTD | -- | $29,217.60 | 2,029 | BZ7PJQ1 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $28,924.48 | 3,272 | BMNDK09 |
0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $27,659.44 | 2,348 | BMWXFT4 |
0.03% | SLRN | ACELYRIN INC | -- | $27,170.25 | 6,393 | BQPF874 |
0.03% | BMEA | BIOMEA FUSION INC | -- | $27,096.94 | 2,342 | BNKF6N0 |
0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $26,574.75 | 9,525 | BJ5FZ74 |
0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $26,441.25 | 16,025 | BWFZX59 |
0.03% | TRML | TOURMALINE BIO INC | -- | $26,424.22 | 1,682 | BQ80NC6 |
0.03% | REPL | REPLIMUNE GROUP INC | -- | $26,133.84 | 4,033 | BDDVW37 |
0.03% | MXCT | MAXCYTE INC | -- | $25,719.12 | 6,804 | BKMQF66 |
0.03% | HROW | HARROW INC | -- | $24,030.72 | 2,304 | BHNDW86 |
0.03% | PGEN | PRECIGEN INC | -- | $22,885.80 | 16,347 | BKM5C84 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $22,837.70 | 8,215 | BNG1NK8 |
0.03% | ATAI | ATAI LIFE SCIENCES NV | -- | $22,351.15 | 10,903 | BN6M8F1 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $21,980.64 | 5,792 | BJFSR99 |
0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $21,827.25 | 1,335 | BL95N25 |
0.03% | CRBU | CARIBOU BIOSCIENCES INC | -- | $21,431.52 | 5,808 | BNYJR68 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $21,275.10 | 5,526 | BLN9Z50 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $21,264.50 | 25,336 | 2301938 |
0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $20,828.26 | 4,174 | BFYQFJ2 |
0.02% | ERAS | ERASCA INC | -- | $20,739.07 | 9,923 | BNLYBF3 |
0.02% | TERN | TERNS PHARMACEUTICALS INC | -- | $20,609.56 | 4,057 | BMDJ0C9 |
0.02% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $19,892.79 | 5,391 | BYTYP72 |
0.02% | RAPT | RAPT THERAPEUTICS INC | -- | $18,454.08 | 2,256 | BK5T6R0 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $18,214.56 | 3,892 | BMG99Y1 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $18,011.52 | 3,776 | B12W3P6 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $16,283.52 | 3,168 | BP48134 |
0.02% | ACIU | AC IMMUNE SA | -- | $16,225.00 | 6,490 | BZC0D70 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $15,876.00 | 9,072 | BLR7H87 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $15,062.72 | 7,312 | BRK0149 |
0.02% | QURE | UNIQURE NV | -- | $14,368.08 | 3,144 | BJFSR88 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $14,201.46 | 4,641 | BYPFK63 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $11,367.16 | 12,501 | BBFL7S1 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $10,363.71 | 20,715 | BM9CKX3 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,586.57 | 4,449 | BPCK358 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,871.60 | 4,660 | BYV2W40 |
0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $5,269.95 | 3,585 | BM8MVZ3 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,741.48 | 2,188 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,786,645.85 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $9,711,719.08 | 9,711,719 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|